Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs. Founded in 2018, Tyra Biosciences is backed by investors that include Canaan Partners, RA Capital Management, Alta Partners, and Boxer Capital and is headquartered in Carlsbad.